Laboratory of Molecular ImmunologySeoul National University College of Medicine

14. Monovalent Anti-CD3 Antibodies Effectively Eliminate the TCR-Positive Fraction of TCR-Deleted Allogeneic CAR-T Cells to Prevent GVHD. Immune Network. 2024, 24(6):e43.

13. Improved safety of chimeric antigen receptor T cells indirectly targeting antigens via switchable adapters. Nature Communications. 2024, 18;15(1):9917.

12. The optimized core peptide derived from CABIN1 efficiently inhibits calcineurin-mediated T-cell activation. Exp Mol Med. 2022, 54(5):613–625.

11. Local adenoviral delivery of soluble CD200R-Ig enhances antitumor immunity by inhibiting CD200-β-catenin-driven M2 macrophage. Mol Ther Oncolytics, 2021, 17;23:138-150.

10. IDO1 scavenges reactive oxygen species in myeloid-derived suppressor cells to prevent graft-versus-host disease. Proc Natl Acad Sci U S A. 2021, 9;118(10).

9. Induction of the IL-1RII decoy receptor by NFAT/FOXP3 blocks IL-1β-dependent response of Th17 cells. Elife. 2021, 10:e61841.

8. IL-7Rαlow CD8+ T Cells from Healthy Individuals Are Anergic with Defective Glycolysis. J Immunol. 2020, 205 (11): 2968–2978.

7. Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G-Associated Disease in Korean Children. J Clin Neurol. 2020, 16(3):461-469.

6. Refining cell-based assay to detect MOG-IgG in patients with central nervous system inflammatory diseases. Mult Scler Relat Disord. 2020, 40:101939.

5. Ndrg1 is a T-cell clonal anergy factor negatively regulated by CD28 costimulation and interleukin-2. Nature Communications. 2015, 6:8698.

4. Memory programming in CD8+ T-cell differentiation is intrinsic and is not determined by CD4 help. Nature Communications. 2015, 6:7994.

3. Low-dose cisplatin converts the tumor microenvironment into a permissive state for HSVtk-induced antitumor immunity in HPV16-related tonsillar carcinoma. Cancer Lett. 2015, 356(2 Pt B):743-50

2. The Role of T Cell Tolerance in the Pathogenesis and Treatment of Autoimmune Diseases. Journal of Multiple Sclerosis. 2013, 4(1):13-18.

1. Adenovirus expressing both thymidine kinase and soluble PD1 enhances anti-tumor immunity by strengthening CD8 T cell response. Molecular Therapy. 2013, 21(3):688-95.